JACC: CardioOncology Pulse › Podcasts

JACC: CardioOncology Pulse Podcasts

NEW Cardiovascular Considerations Before Cancer Therapy

Sivatharshini Ramalingam, Charlotte Manisty

December 18, 2024

Sivatharshini Ramalingam, MD, and Charlotte Manisty, MBBS, PhD, discuss JACC: CardioOncology Expert Panel Recommendations for cardiovascular risk evaluation prior to cancer treatment, cardiac nuances of therapy and highlight evidence gaps for future direction of research.

Sivatharshini
Ramalingam

Charlotte Manisty

NEW Effects of Sacubitril/Valsartan on Prevention of Cardiotoxicity in High-Risk Patients Undergoing Anthracycline Chemotherapy - SARAH Trial

Bonnie Ky, Marcely Gimenes Bonatto

November 26, 2024

Bonnie Ky, MD, and Marcely Gimenes Bonatto, MD, discuss the study design, findings, future research questions and the potential clinical impact of the use of sacubitril/valsartan for the prevention of cardiotoxicity in high-risk patients undergoing anthracycline chemotherapy.

Bonnie Ky

Marcely
Gimenes Bonatto

NEW Cardiovascular Considerations During Cancer Therapy

Nicholas Wilcox, Darryl Leong

November 26, 2024

Nicholas Wilcox, MD, MHS, and Darryl Leong, MBBS, MPH, M.Biostat, PhD, discuss JACC: CardioOncology Expert Panel Recommendations for cardioprotection, surveillance of cancer therapy-related cardiotoxicity and permissive cardiotoxicity, while also highlighting key evidence gaps.

Darryl Leong

Nicholas Wilcox

Environmental Health, Cancer and Cardiovascular Disease

Sadeer Al-Kindi, Sarju Ganatra, Sanjay Rajagopalan,
Nicholas Wilcox

October 22, 2024

Sadeer Al-Kindi, MD, Sarju Ganatra, MD, and Sanjay Rajagopalan, MD, discuss the relationship between environmental pollutants and risk of cancer and cardiovascular disease. Moderated by Nicholas Wilcox, MD, MHS.

Sadeer Al-Kindi

Sarju Ganatra

Sanjay
Rajagopalan

Nicholas Wilcox

Cardio-Oncology in Japan

Sivatharshini Ramalingam, Kazuhiro Sase, Yugo Yamashita

October 22, 2024

Sivatharshini Ramalingam, MD, Kazuhiro Sase, MD, PhD and Yugo Yamashita, MD, PhD, discuss evolving cardio-oncology in Japan, focusing on new guidelines, interdisciplinary care, and cancer-related cardiovascular risks.

Sivatharshini
Ramalingam

Kazuhiro Sase

Yugo Yamashita

Cardio-oncology Trials at ESC: Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy

Andrew Nguyen, Ronald Witteles

September 24, 2024

Ron Witteles, MD, and and Andrew Nguyen, MD, discuss the study design and findings of HELIOS-B, and clinical impact of vutrisiran in transthyretin amyloid cardiomyopathy.

Andrew Nguyen

Ronald Witteles

Cardio-Oncology Trials at ESC: Strain Surveillance During Chemotherapy to Improve Cardiovascular Outcomes: The SUCCOUR-MRI Trial

Bonnie Ky, Tom Marwick

September 11, 2024

JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC, and Tom Marwick, MBBS, PhD, MPH, discuss the study design, findings and the use of strain surveillance during chemotherapy to improve cardiovascular outcomes.

Bonnie Ky

Tom Marwick

Cardio-Oncology Trials at ESC: Effects of Intensive vs Standard Blood Pressure Control on Cardiovascular Outcomes in Cancer Survivors: Results From the SPRINT Randomized Trial

Bonnie Ky, Yichao Xiao

September 11, 2024

JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC, and Yichao Xiao, MD discuss the study design, findings, future research questions and the potential clinical impact on the management of blood pressure in cancer survivors.

Bonnie Ky

Yichao Xiao

Cardio-Oncology Trials at ESC: Sacubitril/Valsartan in Primary Prevention of Cancer-Therapy Related Cardiac Dysfunction in Breast Cancer Patients

Bonnie Ky, Yen-Wen Liu, Yu-Ling Hsu

September 11, 2024

JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC, Yen-Wen Liu, MD, PhD, Professor of Medicine, FESC, and Yu-Ling Hsu, MD, discuss the study design, findings and potential implications for clinical practice and future research questions for the prevention of cancer-therapy related cardiac dysfunction in breast cancer patients.

Bonnie Ky

Yen-Wen Liu

Yu-Ling Hsu

Cardio-Oncology Trials at ESC: Use of Polygenic Risk Score for Prediction of Heart Failure in Cancer Survivors

Tom Marwick, Sivatharshini Ramalingam

September 11, 2024

Tom Marwick, MBBS, PhD, MPH, and Sivatharshini Ramalingam, MD, discuss discuss the study design and findings, as well as the future use and potential development of cardio-oncology specific risk scores for prediction of heart failure in cancer survivors.

Tom Marwick

Sivatharshini
Ramalingam

Clonal Hematopoiesis and Risk of Cardiomyopathy During Cancer Treatment

Jennifer Kwan, Andrew Nguyen

August 27, 2024

Jennifer Kwan, MD PhD, and Andrew Nguyen, MD discuss clonal hematopoiesis and the associated risk of cardiotoxicity during solid tumor treatment.

Jennifer Kwan

Andrew Nguyen

Physical Activity and Rehabilitation to Reduce Cardiovascular Risk in Patients With Cancer

Gregory Hundley, Christina Dieli-Conwright, Nicholas Wilcox

August 27, 2024

Gregory Hundley, MD, and Christina Dieli-Conwright, PhD, MPH discuss the importance of physical activity and cardio-oncology rehabilitation to reduce cardiovascular risk in patients with cancer. Moderated by Nicholas Wilcox, MD, MHS.

Gregory Hundley

Christina
Dieli-Conwright

Nicholas Wilcox

Cardio-Oncology Past, Present, and Future

Alexander Lyon, Sivatharshini Ramalingam

August 27, 2024

Alexander Lyon, MD PhD and Sivatharshini Ramalingam, MD discuss the evolution of Dr Lyon's career in cardio-oncology, the current landscape of cardiotoxicity and essential tips for future leaders

Alexander Lyon

Sivatharshini
Ramalingam

Breaking Down Barriers for Women in Academic Medicine

Nosheen Reza, Nicholas Wilcox

July 23, 2024

Nosheen Reza, MD, discusses overcoming barriers for women in academic medicine, navigating the transition to early career faculty, as well as the importance of leadership and mentorship. Moderated by Nicholas Wilcox, MD, MHS.

Nosheen Reza

Nicholas Wilcox

How to Apply for a Research Grant

Eric Chow, Sarah Waliany

July 23, 2024

Eric Chow, MD, MPH discusses how to successfully apply for a research grant. Moderated by Sarah Waliany, MD, MS.

Eric Chow

Sarah Waliany

Highlights from the JACC: CardioOncology Social and Environmental Determinants of Health and Health Disparities Focus Issue

Sadeer Al-Kindi, Arnethea Sutton, Foster Osei Baah

July 3, 2024

Sadeer Al-Kindi, MD, FACC leads a discussion with Arnethea Sutton, PhD and Foster Osei Baah, MS-PhD, RN on the content included in JACC: CardioOncology's inaugural Social and Environmental Determinants of Health and Health Disparities Focus Issue.

Sadeer Al-Kindi

Foster Osei Baah

Arnethea Sutton

Screening Strategies and the Future State of ATTR Amyloidosis: Live from International Society of Amyloidosis Meeting

Ronald Witteles, Mathew Maurer

June 25, 2024

JACC: CardioOncology Deputy Editor Ronald Witteles, MD and Mathew Maurer, MD discuss the present and future state of ATTR amyloidosis diagnosis and treatment.

Ronald Witteles

Mathew Maurer

Combination Therapy and Orthopedic Manifestations of ATTR Amyloidosis: Live from International Society of Amyloidosis Meeting

Ronald Witteles, Mazen Hanna

June 25, 2024

JACC: CardioOncology Deputy Editor Ronald Witteles, MD and Mazen Hanna, MD discuss some of the latest data from the 2024 International Society of Amyloidosis meeting.

Ronald Witteles

Mazen Hanna

Ischemic Heart Disease in Patients with Cancer

Mamas Mamas, Joerg Herrmann, Nicholas Wilcox

June 25, 2024

Mamas Mamas, DPhil, MA, MBBCh and Joerg Herrmann, MD discuss the care of patients with ischemic heart disease and cancer.

Mamas Mamas

Joerg Herrmann

Nicholas Wilcox

SGLT2 Inhibitors and Withdrawal of Neurohormonal Therapy in Cancer Therapy-Related Cardiotoxicity: What Is the Evidence?

Bonnie Ky, Dinesh Thavendiranathan, Husam Abdel-Qadir, Christopher Yu

May 29, 2024

JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC and Dinesh Thavendiranathan, MD, MSc, Husam Abdel-Qadir, MD, PhD and Christopher Yu, MBBS discuss recent studies of SGLT2 inhibitors and withdrawal of neurhormonal therapy for cancer therapy-related cardiotoxicity.

Bonnie Ky

Christopher Yu

Husam
Abdel-Qadir

Dinesh
Thavendiranathan

Cancer Survivorship: The Patient Perspective

Bonnie Ky, Steven Petrow

May 29, 2024

JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC interviews Steven Petrow, an award-winning journalist and book author, who shares his moving story and personal experiences as a survivor of cancer.

Bonnie Ky

Steven
Petrow

Cardio-Oncology in the Older Adult

Nicholas Wilcox, William Dale, Supriya Gupta Mohile, Efrat Dotan

May 29, 2024

William Dale, MD, PhD, Supriya Gupta Mohile, MD, MS and Efrat Dotan, MD discuss how to effectively care for older adults with cancer, incuding challenges and opportunities for the field of cardio-oncology. Moderated by Nicholas Wilcox, MD, MHS.

Nicholas Wilcox

William Dale

Supriya
Gupta Mohile

Efrat Dotan

Clinical Risk Mitigation, Pathophysiology, and Genetics of Anthracycline-Associated Cardiomyopathy

Aarti Asnani, Sarah Waliany

April 23, 2024

Aarti Asnani, MD discusses anthracyline-induced cardiomyopathy, including risk mitigation strategies, underlying pathogenesis, genetic variants associated with increased risk of this adverse event, and gaps in our understanding. Moderated by Sarah Waliany, MD, MS.

Aarti Asnani

Sarah Waliany

Health Incentives, Behavioral Economics and Cardio-Oncology

Alexander Fanaroff, Nicholas Wilcox

April 23, 2024

Alexander Fanaroff, MD, MHS discusses how behavioral economic principles can be used to incentivize healthy behaviors in cardio-oncology. Moderated by Nicholas Wilcox, MD, MHS.

Alexander
Fanaroff

Nicholas Wilcox

The PROACT Trial: Findings and Key Takeaways

Bonnie Ky, David Austin

April 16, 2024

JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC and David Austin, MD, FRCP discuss PROACT, a phase three randomized open label blinded endpoint superiority trial of enalapril to prevent anthracycline induced cardiotoxicity.

Bonnie Ky

David Austin

Top Takeaways on 'Perspective from the FDA: How to Keep Pace with New Drug Development and Drug Safety' at ACC Advancing the Cardiovascular Care of the Cancer Patient

Ana Barac, Laleh Amiri-Kordestani

March 26, 2024

Ana Barac, MD, PhD, and Laleh Amiri-Kordestani, MD, offer a unique perspective on the development and safety of novel therapeutics, with a focus on cardio-oncology.

Ana Barac

Laleh
Amiri-Kordestani

Top Takeaways on 'Surviving and Thriving: Promoting Cardiovascular Health in Adult Survivors of Childhood Cancers' at ACC Advancing the Cardiovascular Care of the Cancer Patient

Richard Cheng, Stephanie Dixon

March 26, 2024

Richard Cheng, MD, and Stephanie Dixon, MD, provide a review on practical takeaways for cardio-oncologists who are caring for adult survivors of childhood cancer.

Richard Cheng

Stephanie Dixon

Top Takeaways on 'Spotlight on Lung Cancer: Insights into Radiation, Immune Checkpoint Inhibitor, and Epidermal Growth Factor Receptor Therapies' at ACC Advancing the Cardiovascular Care of the Cancer Patient

Teresa López-Fernández, Lova Sun

March 26, 2024

Teresa López-Fernández, MD, and Lova Sun, MD, MSCE discuss the key cardiotoxicities for lung cancer therapy, including radiation, epidermal growth factor receptor and immune checkpoint inhibitor therapy.

Teresa
López-Fernández

Lova Sun

Induced Pluripotent Stem Cells in Cardio-Oncology

Joseph Wu, Nicholas Wilcox

March 26, 2024

Joseph Wu, MD, PhD discusses how stem cells are being employed to better understand mechanisms of cancer therapy-related cardiotoxicity. Moderated by Nicholas Wilcox, MD, MHS.

Joseph Wu

Nicholas Wilcox

Top Takeaways on 'Harmony in Hematology: Cardiovascular Risk Mitigation and Monitoring in Chronic Lymphocytic Leukemia' at ACC Advancing the Cardiovascular Care of the Cancer Patient

Daniel Addison, Danielle Shafer

February 27, 2024

Daniel Addison, MD, and Danielle Shafer, DO, discuss the latest updates in the prevention and treatment of cardiovascular disease in patients with chronic lymphocytic leukemia.

Daniel Addison

Danielle Shafer

Top Takeaways on 'Decoding Immunotherapy: Applying Diagnostic Criteria and Navigating the Complexities of Management' at ACC Advancing the Cardiovascular Care of the Cancer Patient

Daniel Addison, Danielle Shafer

February 27, 2024

Nicolas Palaskas, MD, and Susan Dent, MD, provide a review of the latest developments in the diagnosis and management of diverse immune checkpoint-related adverse cardiovascular events, including myocarditis.

Nicolas Palaskas

Susan Dent

Radiation Therapy for Lung Cancer and Risk of Cardiovascular Disease

Katelyn Atkins, Sarah Waliany

February 27, 2024

Katelyn Atkins, MD, PhD discusses cardiovascular diseases associated with radiation therapy and risk mitigation approaches. Moderated by Sarah Waliany, MD, MS.

Katelyn Atkins

Sarah Waliany

Cardio-Oncology Education: Leading a Successful Fellowship Program

Joshua Mitchell, Benedicte Lefebvre, Vlad Zaha, Nicholas Wilcox

January 23, 2024

Joshua Mitchell, MD, Benedicte Lefebvre, MD and Vlad Zaha, MD, PhD share their experiences leading successful cardio-oncology fellowship programs and the future of cardio-oncology education and training. Moderated by Nicholas Wilcox, MD, MHS.

Joshua Mitchell

Benedicte
Lefebvre

Vlad Zaha

Nicholas Wilcox

Building a Cardio-Oncology Service: The Leap from Fellowship to Consultant

Satish Ramkumer, Daniel Chen, Alexandra Murphy

January 23, 2024

Satish Ramkumer, MD, and Daniel Chen, MD, share their experiences starting a cardio-oncology service in Australia. Moderated by Alexandra Murphy, MD, PhD.

Satish Ramkumer

Daniel Chen

Alexandra Murphy

Cardiac Metabolism and Cardio-Oncology

Anja Karlstaedt, Nicholas Wilcox

January 23, 2024

Anja Karlstaedt, MD, PhD discusses how cardiac metabolism, including SGLT2-inhibitors and GLP-1 receptor agonists, may inform cardioprotective strategies in cardio-oncology. Moderated by Nicholas Wilcox, MD, MHS.

Anja Karlstaedt

Nicholas Wilcox

Starting a Cardio-Oncology Service: Experiences and Lessons Learned

Stephen Nicholls, Alexandra Murphy

December 19, 2023

Stephen Nicholls, MD, shares his experience starting a cardio-oncology service in Australia. Moderated by Alexandra Murphy, MD, PhD.

Stephen Nicholls

Alexandra Murphy

The Role of CMR and Strain Imaging in Cardio-Oncology

Bonnie Ky, Ana Barac, Jennifer Liu

December 19, 2023

Ana Barac, MD, PhD, Jennifer Liu, MD, and Bonnie Ky, MD, MSCE, discuss the role of cardiac magnetic resonance and strain imaging in cardio-oncology.

Bonnie Ky

Ana Barac

Jennifer Liu

Permissive Cardiotoxicity

Bonnie Ky, Charlie Porter

December 19, 2023

Charlie Porter, MD, and Bonnie Ky, MD, MSCE, discuss the concept of permissive cardiotoxicity and applications for patient care in cardio-oncology.

Bonnie Ky

Charlie Porter

SGLT2 Inhibitors and Genetics in Cardio-Oncology: What We Can Learn From Our Heart Failure Colleagues

Bonnie Ky, Dimitrios Farmakis

November 21, 2023

Dimitrios Farmakis, MD, PhD, and Bonnie Ky, MD, MSCE, discuss SGLT-2 inhibitors and genetics, and applications for cardio-oncology practice.

Bonnie Ky

Dimitrios Farmakis

Novel Biomarkers of Cancer Therapy-Related Cardiotoxicity

Bonnie Ky, James Januzzi, Nicholas Wilcox

November 21, 2023

James Januzzi, MD, and Bonnie Ky, MD, MSCE discuss the discovery of novel biomarkers of cancer therapy-related cardiotoxicity. Moderated by Nicholas Wilcox, MD, MHS.

Bonnie Ky

James Januzzi

Nicholas Wilcox

Cardiovascular Toxicities Associated With Renal Cell Carcinoma Therapies

Sumanta Pal, Sarah Waliany

November 21, 2023

Sumanta Pal, MD, discusses the treatment of patients with metastatic renal cell carcinoma (mRCC), management of cardiovascular toxicities associated with therapies for mRCC, and the future treatment landscape of mRCC. Moderated by Sarah Waliany, MD, MS.

Sumanta Pal

Sarah Waliany

Cancer Development in Patients With Heart Failure

Bonnie Ky, Rudolf de Boer, Peter van der Meer

October 24, 2023

Rudolf de Boer, MD, Peter van der Meer, MD, and Bonnie Ky, MD, MSCE, discuss the development of cancer in patients with heart failure.

Bonnie Ky

Rudolf
de Boer

Peter
van der Meer

Interdisciplinary Collaboration in Cardio-Oncology: The Role of the Oncologist

Susan Dent, Alexandra Murphy

October 24, 2023

Susan Dent, MD, discusses the importance of cross-disciplinary collaboration in cardio-oncology. Moderated by Alexandra Murphy, MD, PhD.

Susan Dent

Alexandra Murphy

Improving Outcomes for Survivors of Childhood Cancer

Greg Armstrong, Nicholas Wilcox

October 24, 2023

Greg Armstrong, MD, MSCE discusses the St. Jude Childhood Cancer Survivor Study and opportunities to understand the long-term cardiovascular outcomes of cancer and its therapies. Moderated by Nicholas Wilcox, MD, MHS.

Greg Armstrong

Nicholas Wilcox

International Perspectives: Cardio-Oncology in Portugal

Manuela Fiuza, Bonnie Ky

October 3, 2023

Manuela Fiuza, MD, and Bonnie Ky, MD, MSCE discuss the development of a cardio-oncology service in Portugal.

Manuela Fiuza

Bonnie Ky

How to Build a Career as a Cardiovascular Investigator

Bonnie Ky, Borja Ibáñez

October 3, 2023

Borja Ibáñez, MD, PhD and Bonnie Ky, MD, MSCE, discuss how to build a career as a cardiovascular investigator.

Bonnie Ky

Borja Ibáñez

ESC 2023 JACC: CardioOncology Sim Pub: Chest Pain in Cancer Patients: Prevalence of Myocardial Infarction and Performance of High-Sensitivity Cardiac Troponins

Bonnie Ky, Paolo Bima, Christian E. Mueller

September 5, 2023

Paolo Bima, MD and Professor Christian E. Mueller MD, FESC discuss key takeaways from their study on prevalence of myocardial infarction in cancer patients and review the clinical implications of their findings. Moderated by JACC: CardioOncology Editor-in-Chief Bonnie Ky, MD, MSCE, FACC.

Bonnie Ky

Paolo Bima

Christian E. Mueller

How to Develop a Research Career

Carl June, Nicholas Wilcox

September 19, 2023

Carl June, MD discusses the future of immunotherapy for cancer and cardiovascular disease, potential adverse cardiovascular effects of CAR-T therapy, and provides advice to aspiring physician-scientists. Moderated by Nicholas Wilcox, MD, MHS.

Carl June

Nicholas Wilcox

Successful Leadership in Clinical Trials

Roxana Mehran, Alex Murphy

September 19, 2023

Roxana Mehran, MD discusses her career in clinical trials, improving representation of women in leadership roles, and advice to junior trainees. Moderated by Alex Murphy, MD, PhD.

Roxana Mehran

Alex Murphy

Cardiovascular Immune-Related Adverse Events and Role of Biomarkers in Detection/Management

Kerry Reynolds, Han Zhu, Sarah Waliany

September 19, 2023

Kerry Reynolds, MD, and Han Zhu, MD, discuss the role of biomarkers in surveillance and management of cardiovascular IRAEs and review future directions in the field of IRAEs. Moderated by Sarah Waliany, MD, MS.

Kerry Reynolds

Han Zhu

Sarah Waliany

One Year After the ESC Guidelines: Impact and Next Steps

Bonnie Ky, Teresa López-Fernández

September 5, 2023

Teresa López-Fernández, MD, Co-Chair of 2022 ESC Cardio-Oncology Guidelines, reflects on key takeaways from the guidelines, changes in perspectives over the past year, and future directions in cardio-oncology. Moderated by JACC: CardioOncology Editor-in-Chief Bonnie Ky, MD, MSCE, FACC.

Bonnie Ky

Teresa López-Fernández

International Perspectives: Cardio-Oncology in Mexico

Bonnie Ky, Montserrat Carrillo-Estrada

September 5, 2023

Montserrat Carrillo-Estrada, MD discusses her experience starting a cardio-oncology program in Mexico and reviews the current landscape of cardio-oncology clinical care and research in Mexico. Moderated by JACC: CardioOncology Editor-in-Chief Bonnie Ky, MD, MSCE, FACC.

Bonnie Ky

Montserrat Carrillo-Estrada

Reflection on the Impact of the 2022 ESC Guidelines for Our Community

Bonnie Ky, Alexander Lyon

September 5, 2023

Alexander Lyon, MA, BM BCh, PhD, Co-Chair of 2022 ESC Cardio-Oncology Guidelines, reflects on key takeaways from the guidelines and the impact of the guidelines on the field of cardio-oncology. Moderated by JACC: CardioOncology Editor-in-Chief Bonnie Ky, MD, MSCE, FACC.

Bonnie Ky

Alexander Lyon

Cardiovascular Risks in Our Men with Prostate Cancer

Bonnie Ky, Darryl Leong

September 5, 2023

Darryl Leong, MBBS, MPH M.Biostat, PhD, discusses cardiovascular risks in men with prostate cancer and reviews critical topics such as comparative risk of GnRH agonists versus antagonists. Moderated by JACC: CardioOncology Editor-in-Chief Bonnie Ky, MD, MSCE, FACC.

Bonnie Ky

Darryl Leong

Understanding and Overcoming Disparities in Cardio-Oncology

Bonnie Ky, Clyde Yancy

August 15, 2023

JACC: CardioOncology Editor-in-Chief Bonnie Ky, MD, MSCE, FACC, discusses ongoing work to advance equity in cardio-oncology clinical care, research and training with Clyde Yancy, MD, MSc, MACC.

Bonnie Ky

Clyde Yancy

The Cardiologist's Perspective with Daniela Cardinale

Daniela Cardinale, Sarah Waliany

May 30, 2023

Daniela Cardinale, MD, PhD discusses her career as a cardio-oncologist and reviews the role of biomarkers in the field of cardio-oncology. Moderated by Sarah Waliany, MD, MS.

Daniela Cardinale

Sarah Waliany

How to Develop an Educational Collaboration in Cardio-Oncology

Joseph R. Carver, Tochukwu Okwuosa, Sarah Waliany

May 30, 2023

Joseph R. Carver, MD and Tochukwu (Tochi) Okwuosa, DO, discuss how to develop educational collaborations in the field of cardio-oncology. Moderated by Sarah Waliany, MD, MS.

Joseph R. Carver

Tochukwu
Okwuosa

Sarah Waliany

Cardiovascular Toxicities in CML and SoMe in Cardio-Oncology

Michael Fradley, Naveen Pemmaraju, Sarah Waliany

May 30, 2023

Michael Fradley, MD, and Naveen Pemmaraju, MD, provide overview of treatment landscape of chronic myeloid leukemia, review cardiovascular toxicities of BCR-ABL TKIs, and discuss role of social media in cardio-oncology. Moderated by Sarah Waliany, MD, MS.

Michael Fradley

Naveen
Pemmaraju

Sarah Waliany

Top Takeaways on Amyloidosis at ACC Advancing the Cardiovascular Care of the Oncology Patient

Bonnie Ky, Ronald Witteles

May 2, 2023

JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC and Ronald Witteles, MD, FACC discuss the key takeaways from the session on Amyloidosis at the ACC Advancing the Cardiovascular Care of the Oncology Patient course.

Bonnie Ky

Ronald Witteles

Top Takeaways on Balancing Bleeding and Thrombosis at ACC Advancing the Cardiovascular Care of the Oncology Patient

Craig Beavers, Agnes Lee

May 2, 2023

Craig Beavers, PharmD, FACC and Agnes Lee, MD discuss the key takeaways from their session on Balancing Bleeding and Thrombosis on Cardio-Oncology Guidelines at the ACC Advancing the Cardiovascular Care of the Oncology Patient course.

Craig Beavers

Agnes Lee

Top Takeaways on the Cardiologist and Oncologist Perspectives on Cardio-Oncology Guidelines at ACC Advancing the Cardiovascular Care of the Oncology Patient

Matthew Ehrhardt, Joseph Sparano, and Kathleen Zhang

May 2, 2023

Matthew Ehrhardt, MD, Joseph Sparano, MD, and Kathleen Zhang, MD, FACC discuss the key takeaways from their session on The Cardiologist and Oncologist Perspectives on Cardio-Oncology Guidelines at the ACC Advancing the Cardiovascular Care of the Oncology Patient course.

Matthew
Ehrhardt

Joseph Sparano

Kathleen Zhang

Top Takeaways on New Strategies in Breast Cancer Treatment and Cardiovascular Health Implications at ACC Advancing the Cardiovascular Care of the Oncology Patient

Anne Blaes, Joseph Sparano

May 2, 2023

Anne Blaes, MD and Joseph Sparano, MD discuss the key takeaways from their session on New Strategies in Breast Cancer Treatment and Implications for Cardiovascular Health at the ACC Advancing the Cardiovascular Care of the Oncology Patient course.

Anne Blaes

Joseph Sparano

Top Takeaways on Cardiovascular Concerns of Radiation Protocols at ACC Advancing the Cardiovascular Care of the Oncology Patient

Jean Wright, Phillip Cuculich, Daniel Addison

May 2, 2023

Jean Wright, MD, Phillip Cuculich, MD, and Daniel Addison, MD, discuss the key takeaways from their session on Cardiovascular Concerns of Radiation Protocols at the ACC Advancing the Cardiovascular Care of the Oncology Patient course.

Jean Wright

Phillip Cuculich

Daniel Addison

Top Takeaways on LV Dysfunction and Heart Failure at ACC Advancing the Cardiovascular Care of the Oncology Patient

Richard Cheng, Matthew Ehrhardt

May 2, 2023

Richard Cheng, MD, FACC and Matthew Ehrhardt, MD discuss the key takeaways from their session on LV Dysfunction and Heart Failure at the ACC Advancing the Cardiovascular Care of the Oncology Patient course.

Richard Cheng

Matthew Ehrhardt

Top Takeaways on Landscape of Cellular Therapy at ACC Advancing the Cardiovascular Care of the Oncology Patient

Ronald Witteles, Patrick Reagan

April 25, 2023

Ronald Witteles, MD, FACC and Patrick Reagan, MD discuss the key takeaways from their session on Landscape of Cellular Therapy at the ACC Advancing the Cardiovascular Care of the Oncology Patient course.

Ronald Witteles

Patrick Reagan

Top Takeaways on Cardiovascular Disparities in Cancer Care and Survivorship at ACC Advancing the Cardiovascular Care of the Oncology Patient

Bonnie Ky, Tiffany M. Powell-Wiley

April 25, 2023

JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC and Tiffany M. Powell-Wiley, MD MPH discuss the key takeaways from their session on Cardiovascular Disparities in Cancer Care and Survivorship at the ACC Advancing the Cardiovascular Care of the Oncology Patient course.

Bonnie Ky

Tiffany M.
Powell-Wiley

Barriers to Access to Cardio-Oncology Care

Narjust Florez, Shruti Patel, Giselle Alexandra Suero-Abreu, and Sarah Waliany

April 25, 2023

Narjust Florez, MD, Shruti Patel, MD, and Giselle Alexandra Suero-Abreu, MD, PhD, MSc discuss the impact of structural barriers and social determinants of health on limiting access to cardio-oncology care, describe strategies for ensuring equitable representation of underserved patients in clinical trials, and consider changes needed at institutional and policy levels to reduce disparities in access to care. Moderated by Sarah Waliany, MD, MS.

Narjust Florez

Shruti Patel

Giselle Alexandra
Suero-Abreu

Sarah Waliany

Getting Into Fellowship: Standing out as a Candidate

Erin Aakhus, Dipti Gupta, Eric Yang, and Sarah Waliany

April 4, 2023

Erin Aakhus, MD, MSHP, Dipti Gupta, MD, MPH and Eric Yang, MD, FACC share their perspectives as fellowship Program Directors or Associate Program Directors on the process of applying for fellowship in cardiology, hematology/oncology, or cardio-oncology and how applicants can stand out. Moderated by Sarah Waliany, MD, MS.

Erin Aakhus

Dipti Gupta

Eric Yang

Sarah Waliany

Women with Careers in Cardio-Oncology

Carmen Bergom, Alicia Morgans, June-Wha Rhee, and Sarah Waliany

April 4, 2023

Carmen Bergom, MD, PhD, Alicia Morgans, MD, MPH, and June-Wha Rhee, MD discuss their experiences as women with careers in cardio-oncology, the importance of mentorship and sponsorship, rewards and challenges of building research careers, striking a balance with personal and family lives, negotiation strategies to address pay disparities, and institutional policies needed to advance the careers of women. Moderated by Sarah Waliany, MD, MS.

Carmen Bergom

Alicia Morgans

June-Wha Rhee

Sarah Waliany

The Hematologist’s Perspective with Raúl Córdoba

Raúl Córdoba and Sarah Waliany

April 4, 2023

Raúl Córdoba, MD, PhD, discusses cardiotoxicities of treatments for hematological malignancies, the importance of geriatric hematology, and his views on the STOP-CA trial. Moderated by Sarah Waliany, MD, MS.

Raúl Córdoba

Sarah Waliany

Key Takeaways From the ACC.23 Session on Cardiac Amyloidosis in Real-World Clinical Practice

Ronald M. Witteles and Sharmila Dorbala

March 16, 2023

Ronald M. Witteles, MD and Sharmila Dorbala, MD, MPH discuss key takeaways from the ACC.23 session on Cardiac Amyloidosis in Real-World Clinical Practice

Ronald Witteles

Sharmila Dorbala

Statin Cardioprotection and the STOP-CA Trial Presented at ACC.23

Bonnie Ky, Ronald M. Witteles, Marielle Scherrer-Crosbie, and W. Greg Hundley

March 16, 2023

Bonnie Ky, MD, MSCE, FACC, Ronald M. Witteles, MD, Marielle Scherrer-Crosbie, MD, PhD, and W. Greg Hundley, MD discuss the topic of statin cardioprotection, the STOP-CA trial presented at ACC.23, the PREVENT study published in NEJM Evidence, and the key takeaways of these two studies. Future directions and goals for the field are also discussed.

Bonnie Ky

Ronald Witteles

W. Greg Hundley

Marielle
Scherrer-Crosbie

Profile of Young Investigator Award Winner at ACC.23

Bonnie Ky and Megan Mulholland

March 16, 2023

Bonnie Ky, MD, MSCE, FACC and Megan Mulholland, MSc, the 2022 JACC: CardioOncology Young Author Achievement Award winner, discuss science and training in the field, career goals and plans, and her original research manuscript on immune therapy and atherosclerosis completed with the mentorship of Daniel Engelbertsen, PhD, now online in JACC: CardioOncology.

Bonnie Ky

Megan Mulholland

How to Find a Mentor and Advocate in Cardio-Oncology

Susan Dent, Kelly Getz, Tomas Neilan, and Sarah Waliany

January 31, 2023

Susan Dent, MD, Kelly Getz, MPH, PhD, and Tomas Neilan, MD, discuss how to find a mentor and advocate in cardio-oncology. Moderated by Sarah Waliany, MD, MS.

Susan Dent

Kelly Getz

Tomas Neilan

Sarah Waliany

The Trainee's Perspective: How to Find a Mentor in Cardio-Oncology and Role of Peer-to-Peer Mentorship

David Madnick, Nicholas Wilcox, and Sarah Waliany

January 31, 2023

David Madnick, MD, and Nicholas Wilcox, MD, discuss how they became interested in cardio-oncology, how they found their mentors, and the role of peer-to-peer mentorship. Moderated by Sarah Waliany, MD, MS.

David Madnick

Nicholas Wilcox

Sarah Waliany

The Oncologist’s Perspective with Anne Blaes

Anne Blaes and Sarah Waliany

January 31, 2023

Anne Blaes, MD, MS, discusses how she transitioned into cardio-oncology with Sarah Waliany, MD, MS.

Anne Blaes

Sarah Waliany

The Cardiologist’s Perspective with Javid Moslehi

Javid Moslehi and Sarah Waliany

January 31, 2023

Javid Moslehi, MD, discusses how he transitioned into cardio-oncology with Sarah Waliany, MD, MS.

Javid Moslehi

Sarah Waliany